148 related articles for article (PubMed ID: 12270618)
1. Physical properties of chitosan pellets produced by extrusion-spheronisation: influence of formulation variables.
Santos H; Veiga F; Pina M; Podczeck F; Sousa J
Int J Pharm; 2002 Oct; 246(1-2):153-69. PubMed ID: 12270618
[TBL] [Abstract][Full Text] [Related]
2. The influence of chitosan and sodium alginate and formulation variables on the formation and drug release from pellets prepared by extrusion/spheronisation.
Chatchawalsaisin J; Podczeck F; Newton JM
Int J Pharm; 2004 May; 275(1-2):41-60. PubMed ID: 15081137
[TBL] [Abstract][Full Text] [Related]
3. Extruded and spheronized beads containing no microcrystalline cellulose: influence of formulation and process variables.
Agrawal AM; Howard MA; Neau SH
Pharm Dev Technol; 2004; 9(2):197-217. PubMed ID: 15202579
[TBL] [Abstract][Full Text] [Related]
4. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. I. Influence of type and fraction of filler.
Thommes M; Kleinebudde P
Eur J Pharm Biopharm; 2006 May; 63(1):59-67. PubMed ID: 16326085
[TBL] [Abstract][Full Text] [Related]
5. Compaction, compression and drug release characteristics of xanthan gum pellets of different compositions.
Santos H; Veiga F; Pina ME; Sousa JJ
Eur J Pharm Sci; 2004 Feb; 21(2-3):271-81. PubMed ID: 14757499
[TBL] [Abstract][Full Text] [Related]
6. Influence of starting material particle size on pellet surface roughness.
Sarkar S; Ang BH; Liew CV
AAPS PharmSciTech; 2014 Feb; 15(1):131-9. PubMed ID: 24198222
[TBL] [Abstract][Full Text] [Related]
7. The application of non-contact laser profilometry to the determination of permanent structural changes induced by compaction of pellets. I. Pellets of different composition.
Bashaiwoldu AB; Podczeck F; Newton JM
Eur J Pharm Sci; 2004 Feb; 21(2-3):143-54. PubMed ID: 14757485
[TBL] [Abstract][Full Text] [Related]
8. Factorial designed experiment to study the effects of excipients on the mechanical properties of pellets.
Bashaiwoldu AB; Podczeck F; Newton JM
J Pharm Pharmacol; 2006 Oct; 58(10):1305-9. PubMed ID: 17034652
[TBL] [Abstract][Full Text] [Related]
9. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. II. Influence of drug and filler type.
Thommes M; Kleinebudde P
Eur J Pharm Biopharm; 2006 May; 63(1):68-75. PubMed ID: 16325384
[TBL] [Abstract][Full Text] [Related]
10. Effect of disintegrants on the properties of multiparticulate tablets comprising starch pellets and excipient granules.
Mehta S; De Beer T; Remon JP; Vervaet C
Int J Pharm; 2012 Jan; 422(1-2):310-7. PubMed ID: 22101283
[TBL] [Abstract][Full Text] [Related]
11. Physicochemical properties of granulating liquids and their influence on microcrystalline cellulose pellets obtained by extrusion-spheronisation technology.
Dreu R; Sirca J; Pintye-Hodi K; Burjan T; Planinsek O; Srcic S
Int J Pharm; 2005 Mar; 291(1-2):99-111. PubMed ID: 15707736
[TBL] [Abstract][Full Text] [Related]
12. Drug release from reservoir pellets compacted with some excipients of different physical properties.
Tunón A; Börjesson E; Frenning G; Alderborn G
Eur J Pharm Sci; 2003 Dec; 20(4-5):469-79. PubMed ID: 14659491
[TBL] [Abstract][Full Text] [Related]
13. The influence of liquid binder on the liquid mobility and preparation of spherical granules by the process of extrusion/spheronization.
Boutell S; Newton JM; Bloor JR; Hayes G
Int J Pharm; 2002 May; 238(1-2):61-76. PubMed ID: 11996811
[TBL] [Abstract][Full Text] [Related]
14. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
[TBL] [Abstract][Full Text] [Related]
15. Development of starch-based pellets via extrusion/spheronisation.
Dukić A; Mens R; Adriaensens P; Foreman P; Gelan J; Remon JP; Vervaet C
Eur J Pharm Biopharm; 2007 Apr; 66(1):83-94. PubMed ID: 17045467
[TBL] [Abstract][Full Text] [Related]
16. Use of extrusion aids for successful production of Kollidon
Loka NC; Saripella KK; Pinto CA; Neau SH
Drug Dev Ind Pharm; 2018 Apr; 44(4):632-642. PubMed ID: 29183166
[TBL] [Abstract][Full Text] [Related]
17. The preparation of pellets containing a surfactant or a mixture of mono- and di-gylcerides by extrusion/spheronization.
Newton JM; Pinto MR; Podczeck F
Eur J Pharm Sci; 2007 Mar; 30(3-4):333-42. PubMed ID: 17223021
[TBL] [Abstract][Full Text] [Related]
18. Melt-in-mouth pellets of fexofenadine hydrochloride using crospovidone as an extrusion-spheronisation aid.
Jain SP; Mehta DC; Shah SP; Singh PP; Amin PD
AAPS PharmSciTech; 2010 Jun; 11(2):917-23. PubMed ID: 20499219
[TBL] [Abstract][Full Text] [Related]
19. The influence of plate design on the properties of pellets produced by extrusion and spheronization.
Michie H; Podczeck F; Newton JM
Int J Pharm; 2012 Sep; 434(1-2):175-82. PubMed ID: 22659150
[TBL] [Abstract][Full Text] [Related]
20. Chitosan-kaolin coprecipitate as disintegrant in microcrystalline cellulose-based pellets elaborated by extrusion-spheronization.
Goyanes A; Souto C; Martínez-Pacheco R
Pharm Dev Technol; 2013 Feb; 18(1):137-45. PubMed ID: 22309024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
